Universität zu Köln

Vogel, Constanze, Malter, Wolfram, Morgenstern, Bernd, Ludwig, Sebastian, Vehreschild, Joerg Janne, Hamacher, Stefanie ORCID: 0000-0003-2158-9101, Mallmann, Peter, Kirn, Verena and Thangarajah, Fabinshy (2019). The Role of Previous Therapies and Sites of Metastasis as Influencing Factors on Discordance of ER, PR and HER2 Status Between Primary and Metastasized Breast Cancer. Anticancer Res., 39 (5). S. 2647 - 2660. ATHENS: INT INST ANTICANCER RESEARCH. ISSN 1791-7530

Full text not available from this repository.

Abstract

Background/Aim: The aim of the present study was to analyze metastasized breast cancer (BC) patients with regard to the discordance of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). We especially aimed to analyze the association between the change of tumor biology and previous treatment or metastatic sites. Patients and Methods: Patients with metastasized BC who were treated at the Department of Gynecology/Breast Center of the University Hospital of Cologne were analyzed. Results: Loss of HER2 occurred more frequently in lymph node metastases that were not in the axillary region (p=0.026). Letrozole showed a significant correlation with loss of ER and/or PR (p=0.041). Improved overall survival and post-metastasis survival were noticed with a gain of HER2 (p=0.044 and p=0.009, respectively) and concordant positive ER and PR status (p=0.002 and p=0.001, respectively). Conclusion: The discordance of receptors and the dependence of BC on therapies as well as metastatic sites stresses the necessity of early sample taking to offer patients suitable therapy options.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Vogel, Constanze UNSPECIFIED UNSPECIFIED UNSPECIFIED Malter, Wolfram UNSPECIFIED UNSPECIFIED UNSPECIFIED Morgenstern, Bernd UNSPECIFIED UNSPECIFIED UNSPECIFIED Ludwig, Sebastian UNSPECIFIED UNSPECIFIED UNSPECIFIED Vehreschild, Joerg Janne UNSPECIFIED UNSPECIFIED UNSPECIFIED Hamacher, Stefanie UNSPECIFIED orcid.org/0000-0003-2158-9101 UNSPECIFIED Mallmann, Peter UNSPECIFIED UNSPECIFIED UNSPECIFIED Kirn, Verena UNSPECIFIED UNSPECIFIED UNSPECIFIED Thangarajah, Fabinshy UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-149194
DOI:	10.21873/anticanres.13389
Journal or Publication Title:	Anticancer Res.
Volume:	39
Number:	5
Page Range:	S. 2647 - 2660
Date:	2019
Publisher:	INT INST ANTICANCER RESEARCH
Place of Publication:	ATHENS
ISSN:	1791-7530
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language PROGESTERONE-RECEPTOR STATUS; ESTROGEN-RECEPTOR; TISSUE CONFIRMATION; PROGNOSTIC IMPACT; GENE-EXPRESSION; DISEASE; BIOLOGY Multiple languages Oncology Multiple languages
Refereed:	Yes
URI:	http://kups.ub.uni-koeln.de/id/eprint/14919